{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:18:20Z","timestamp":1773263900719,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Progranulin (PGRN), a pleiotropic growth factor, has emerged as an immunoregulatory molecule. Because the roles of PGRN in dermatomyositis (DM) are still unknown, we investigated whether serum PGRN levels are associated with disease activity and prognosis in DM patients, particularly in those with DM complicated with interstitial lung disease (ILD).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The serum levels of PGRN were measured by enzyme-linked immunosorbent assay in patients with DM (n =57; acute\/subacute interstitial pneumonia (A\/SIP): n =17, chronic interstitial pneumonia (CIP): n =24, without ILD: n =16), polymyositis (PM, n =21; including 6 with ILD) and normal healthy controls (NHCs, n =60). We assessed the correlation between the serum PGRN levels and the activity indexes of ILD or prognosis in DM patients with ILD.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Serum PGRN levels were significantly higher in DM patients than in PM patients (<jats:italic>P<\/jats:italic> =0.0025) and in NHCs (<jats:italic>P<\/jats:italic> &lt;0.0001). In DM patients, the levels were significantly higher in patients with A\/SIP than in those with CIP (<jats:italic>P<\/jats:italic> &lt;0.0001) or without ILD (<jats:italic>P<\/jats:italic> =0.0003). The serum PGRN levels in DM patients with ILD significantly correlated with serum ferritin (<jats:italic>r<\/jats:italic><jats:sub>S<\/jats:sub> =0.77, <jats:italic>P<\/jats:italic> &lt;0.0001), lactate dehydrogenase (<jats:italic>r<\/jats:italic><jats:sub>S<\/jats:sub> =0.54, <jats:italic>P<\/jats:italic> =0.0003) and C-reactive protein (<jats:italic>r<\/jats:italic><jats:sub>S<\/jats:sub> =0.48, <jats:italic>P<\/jats:italic> =0.0015) levels. Moreover, in DM patients with ILD, the cumulative survival rate for 6\u00a0months was significantly lower in the group with serum PGRN levels \u2265200\u00a0ng\/ml (67%) than in the group with serum PGRN levels &lt;200\u00a0ng\/ml (100%) (<jats:italic>P<\/jats:italic> =0.0009).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Serum PGRN is associated with disease activity and prognosis of DM with ILD. PGRN may play a role in the pathogenesis of DM and could be a useful biomarker.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0547-z","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T03:15:15Z","timestamp":1423538115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mitoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyasu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ayano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichiro","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuteru","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Arinobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Niiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"547_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","volume":"355","author":"J Callen","year":"2000","unstructured":"Callen J. Dermatomyositis Lancet. 2000;355:53\u20137.","journal-title":"Dermatomyositis Lancet"},{"key":"547_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s100670050139","volume":"18","author":"M Ito","year":"1999","unstructured":"Ito M, Kaise S, Suzuki S, Kazuta Y, Sato Y, Miyata M, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol. 1999;18:462\u20137.","journal-title":"Clin Rheumatol"},{"key":"547_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/sarh.2002.50012","volume":"32","author":"A Schnabel","year":"2003","unstructured":"Schnabel A, Reuter M, Biederer J, Richter C, Gross W. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum. 2003;32:273\u201384.","journal-title":"Semin Arthritis Rheum"},{"key":"547_CR4","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20136.","journal-title":"Arthritis Rheum"},{"key":"547_CR5","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10067-007-0562-9","volume":"26","author":"S Ye","year":"2007","unstructured":"Ye S, Chen X, Lu X, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647\u201354.","journal-title":"Clin Rheumatol"},{"key":"547_CR6","doi-asserted-by":"publisher","first-page":"124S","DOI":"10.1038\/jid.1993.35","volume":"100","author":"RL Euwer","year":"1993","unstructured":"Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol. 1993;100:124S\u20137.","journal-title":"J Invest Dermatol"},{"key":"547_CR7","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol. 2005;32:1719\u201326.","journal-title":"J Rheumatol"},{"key":"547_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/157339710791330740","volume":"6","author":"LA Saketkoo","year":"2010","unstructured":"Saketkoo LA, Ascherman DP, Cottin V, Christopher-Stine L, Danoff SK, Oddis CV. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev. 2010;6:108\u201319.","journal-title":"Curr Rheumatol Rev"},{"key":"547_CR9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35\u00a0years? Chest. 2010;138:1464\u201374.","journal-title":"Chest"},{"key":"547_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/BOR.0b013e32833f1970","volume":"22","author":"A Labirua","year":"2010","unstructured":"Labirua A, Lundberg IE. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol. 2010;22:633\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"547_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, et al. The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford). 2010;49:433\u201340.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49:1354\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh H, Kuwana M, Katsumata Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49:1713\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/s10165-010-0371-x","volume":"21","author":"T Gono","year":"2011","unstructured":"Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol. 2011;21:223\u20137.","journal-title":"Mod Rheumatol"},{"key":"547_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/ard.59.4.257","volume":"59","author":"S Bandoh","year":"2000","unstructured":"Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis. Ann Rheum Dis. 2000;59:257\u201362.","journal-title":"Ann Rheum Dis"},{"key":"547_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/rheumatology\/39.6.632","volume":"39","author":"M Kubo","year":"2000","unstructured":"Kubo M, Ihn H, Yamane K, Kikuchi K, Yazawa N, Soma Y, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford). 2000;39:632\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2796.2006.01704.x","volume":"260","author":"H Satoh","year":"2006","unstructured":"Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung disease. J Intern Med. 2006;260:429\u201334.","journal-title":"J Intern Med"},{"key":"547_CR18","first-page":"414","volume":"26","author":"G Kum\u00e1novics","year":"2008","unstructured":"Kum\u00e1novics G, Minier T, Radics J, P\u00e1link\u00e1s L, Berki T, Czirj\u00e1k L. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato\/polymyositis. Clin Exp Rheumatol. 2008;26:414\u201320.","journal-title":"Clin Exp Rheumatol"},{"key":"547_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2796.2011.02459.x","volume":"271","author":"M Fathi","year":"2012","unstructured":"Fathi M, Barbasso Helmers S, Lundberg IE. KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis. J Intern Med. 2012;271:589\u201397.","journal-title":"J Intern Med"},{"key":"547_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00109-003-0474-3","volume":"81","author":"Z He","year":"2003","unstructured":"He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med. 2003;81:600\u201312.","journal-title":"J Mol Med"},{"key":"547_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/bies.200900086","volume":"31","author":"A Bateman","year":"2009","unstructured":"Bateman A, Bennett HP. The granulin gene family: from cancer to dementia. Bioessays. 2009;31:1245\u201354.","journal-title":"Bioessays"},{"key":"547_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/002215540004800713","volume":"48","author":"R Daniel","year":"2000","unstructured":"Daniel R, He Z, Carmichael KP, Halper J, Bateman A. Cellular localization of gene expression for progranulin. J Histochem Cytochem. 2000;48:999\u20131009.","journal-title":"J Histochem Cytochem"},{"key":"547_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm816","volume":"9","author":"Z He","year":"2003","unstructured":"He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med. 2003;9:225\u20139.","journal-title":"Nat Med"},{"key":"547_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1083\/jcb.200712039","volume":"181","author":"P Van Damme","year":"2008","unstructured":"Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol. 2008;181:37\u201341.","journal-title":"J Cell Biol"},{"key":"547_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med. 2010;207:117\u201328.","journal-title":"J Exp Med"},{"key":"547_CR26","first-page":"2438","volume":"118","author":"K Kessenbrock","year":"2008","unstructured":"Kessenbrock K, Fr\u00f6hlich L, Sixt M, L\u00e4mmermann T, Pfister H, Bateman A, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118:2438\u201347.","journal-title":"J Clin Invest"},{"key":"547_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.immuni.2011.01.018","volume":"34","author":"B Park","year":"2011","unstructured":"Park B, Buti L, Lee S, Matsuwaki T, Spooner E, Brinkmann MM, et al. Granulin is a soluble cofactor for Toll-like receptor 9 signaling. Immunity. 2011;34:505\u201313.","journal-title":"Immunity"},{"key":"547_CR28","doi-asserted-by":"publisher","first-page":"R244","DOI":"10.1186\/ar4087","volume":"14","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M, et al. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity. Arthritis Res Ther. 2012;14:R244.","journal-title":"Arthritis Res Ther"},{"key":"547_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","volume":"29","author":"GT Kim","year":"2010","unstructured":"Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, et al. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol. 2010;29:273\u20139.","journal-title":"Clin Rheumatol"},{"key":"547_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/NEN.0b013e31826bf7f3","volume":"71","author":"A Brunn","year":"2012","unstructured":"Brunn A, Zornbach K, Hans VH, Haypt WF, Deckert M. Toll-like receptors promote inflammation in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 2012;71:855\u201367.","journal-title":"J Neuropathol Exp Neurol"},{"key":"547_CR31","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1365-2133.2012.11145.x","volume":"167","author":"WC Sun","year":"2012","unstructured":"Sun WC, Sun YC, Lin H, Yan B, Shi GX. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease. Br J Dermatol. 2012;167:1236\u201344.","journal-title":"Br J Dermatol"},{"key":"547_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/14397595.2013.844390","volume":"24","author":"H Bilgic","year":"2014","unstructured":"Bilgic H, Ytterberg S, Amin S, McNallan KT, Wilson JC, Koeuth T, et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009;60:3436\u201346.33. Nara M, Komatsuda A, Omokawa A, Togashi M, Okuyama S, Sawada K, et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Mod Rheumatol. 2014;24:633\u20136.","journal-title":"Mod Rheumatol"},{"key":"547_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1152\/japplphysiol.01026.2004","volume":"98","author":"F Haddad","year":"2005","unstructured":"Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol. 2005;98:911\u20137.","journal-title":"J Appl Physiol"},{"key":"547_CR34","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/art.24689","volume":"60","author":"N Okiyama","year":"2009","unstructured":"Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum. 2009;60:2505\u201312.","journal-title":"Arthritis Rheum"},{"key":"547_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter J. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"547_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyositis spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336. A published erratum appears in J Am Acad Dermatol. 2002;46:699.","journal-title":"J Am Acad Dermatol"},{"key":"547_CR37","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. Am J Respir Crit Care Med. 2000;161:646\u201364.","DOI":"10.1164\/ajrccm.161.2.ats3-00"},{"key":"547_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10067-005-1109-6","volume":"24","author":"K Oryoji","year":"2005","unstructured":"Oryoji K, Himeji D, Nagafuji K, Horiuchi T, Tsukamoto H, Nondo H, et al. Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol. 2005;24:637\u201340.","journal-title":"Clin Rheumatol"},{"key":"547_CR39","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/rheumatology\/kes012","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Miyake K, Kawaguchi Y, Kaneko H, Shinozaki M, Yamanaka H. Hyperferritinemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. Rheumatology (Oxford). 2012;51:1336\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00109-010-0677-3","volume":"89","author":"K Kessenbrock","year":"2011","unstructured":"Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med. 2011;89:23\u20138.","journal-title":"J Mol Med"},{"key":"547_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011;332:478\u201384.","journal-title":"Science"},{"key":"547_CR42","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/rheumatology\/41.11.1268","volume":"41","author":"H Ihn","year":"2002","unstructured":"Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, et al. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis\/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford). 2002;41:1268\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"547_CR43","first-page":"1164","volume":"27","author":"H Nakajima","year":"2000","unstructured":"Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen disease. J Rheumatol. 2000;27:1164\u201370.","journal-title":"J Rheumatol"},{"key":"547_CR44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cmet.2011.12.002","volume":"15","author":"T Matsubara","year":"2012","unstructured":"Matsubara T, Mita A, Minami K, Hosooka T, Kitazawa S, Takahashi K, et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab. 2012;15:38\u201350.","journal-title":"Cell Metab"},{"key":"547_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/ar3349","volume":"13","author":"N Jacob","year":"2011","unstructured":"Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011;13:228.","journal-title":"Arthritis Res Ther"},{"key":"547_CR46","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1002\/art.22197","volume":"54","author":"ED Papadimitraki","year":"2006","unstructured":"Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, et al. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006;54:3601\u201311.","journal-title":"Arthritis Rheum"},{"key":"547_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1189\/jlb.0812429","volume":"93","author":"J Jian","year":"2013","unstructured":"Jian J, Konopka J, Liu C. Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol. 2013;93:199\u2013208.","journal-title":"J Leukoc Biol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0547-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0547-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0547-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0547-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:30:57Z","timestamp":1728923457000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0547-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0547-z","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]},"assertion":[{"value":"18 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}